• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Timing of surgery following SARSCoV2 infection: an international prospective cohort study

Mary Wilson

Well-known member
Association of Anaesthetists
First published: 09 March 2021
https://doi.org/10.1111/anae.15458

Timing of surgery following SARS?CoV?2 infection: an international prospective cohort study

COVIDSurg Collaborative

GlobalSurg Collaborative
First published: 09 March 2021

https://doi.org/10.1111/anae.15458SECTIONS


Summary


Perioperative SARSCoV2 infection increases postoperative mortality. The aim of this study was to determine the optimal duration of planned delay before surgery in patients who have had SARSCoV2 infection. This international, multicentre, prospective cohort study included patients undergoing elective or emergency surgery during October 2020. Surgical patients with preoperative SARSCoV2 infection were compared with those without previous SARSCoV2 infection. The primary outcome measure was 30day postoperative mortality. Logistic regression models were used to calculate adjusted 30day mortality rates stratified by time from diagnosis of SARSCoV2 infection to surgery. Among 140,231 patients (116 countries), 3127 patients (2.2%) had a preoperative SARSCoV2 diagnosis. Adjusted 30day mortality in patients without SARSCoV2 infection was 1.5% (95%CI 1.4?1.5). In patients with a preoperative SARSCoV2 diagnosis, mortality was increased in patients having surgery within 0?2 weeks, 3?4 weeks and 5?6 weeks of the diagnosis (odds ratio (95%CI) 4.1% (3.3?4.8), 3.9% (2.6?5.1) and 3.6% (2.0?5.2), respectively). Surgery performed 7 weeks after SARSCoV2 diagnosis was associated with a similar mortality risk to baseline (odds ratio (95%CI) 1.5% (0.9?2.1%)). After a 7 week delay in undertaking surgery following SARSCoV2 infection, patients with ongoing symptoms had a higher mortality than patients whose symptoms had resolved or who had been asymptomatic (6.0% (95%CI 3.2?8.7) vs. 2.4% (95%CI 1.4?3.4) vs. 1.3% (95%CI 0.6?2.0%), respectively). Where possible, surgery should be delayed for at least 7 weeks following SARSCoV2 infection. Patients with ongoing symptoms 7 weeks from diagnosis may benefit from further delay.


https://associationofanaesthetists-p...111/anae.15458
 
Last edited by a moderator:
Back
Top Bottom